Chronic renal insufficiency: a diagnostic and therapeutic approach
- PMID: 9738603
- DOI: 10.1001/archinte.158.16.1743
Chronic renal insufficiency: a diagnostic and therapeutic approach
Abstract
Chronic renal insufficiency ultimately culminating in end-stage renal disease requiring dialysis or transplantation is a major health problem in the United States. The first task confronting the physician caring for a patient with renal disease is to decide whether the renal insufficiency is acute or chronic. The initial differential diagnostic approach to chronic renal insufficiency consists of determining whether the patient has glomerular disease or interstitial or vascular disease on the basis of a careful history taking, urinalysis, and measurement of 24-hour protein excretion. Further refinement of diagnostic considerations often requires serologic studies, renal biopsy, or imaging the urinary tract with ultrasonography or computed tomography. Management considerations begin with the identification and correction of any acute reversible causes of renal insufficiency in patients with chronic renal disease. Recent studies have shown that effective antihypertensive therapy, especially with angiotensin-converting enzyme inhibitors, restriction of dietary protein, and excellent glycemic control in patients with diabetes, can retard the progression of chronic renal disease. Once these therapeutic strategies are in place, it is important to anticipate and treat the multiple manifestations of chronic progressive renal insufficiency: fluid overload, hyperkalemia, metabolic acidosis, abnormalities of calcium, phosphorus, and vitamin D metabolism, and anemia.
Comment in
-
Chronic renal insufficiency.Arch Intern Med. 1999 Apr 12;159(7):757. doi: 10.1001/archinte.159.7.757. Arch Intern Med. 1999. PMID: 10218759 No abstract available.
Similar articles
-
Practical management of chronic renal failure.Am Fam Physician. 1979 Mar;19(3):158-64. Am Fam Physician. 1979. PMID: 425868
-
Evaluation and treatment of chronic renal failure.Indian J Pediatr. 1999 Mar-Apr;66(2):241-53. doi: 10.1007/BF02761215. Indian J Pediatr. 1999. PMID: 10798066 Review.
-
Preventing disease progression in chronic renal failure.Am Fam Physician. 1995 Nov 1;52(6):1783-91. Am Fam Physician. 1995. PMID: 7484688 Review.
-
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.Pharmacoeconomics. 2002;20(1):37-47. doi: 10.2165/00019053-200220010-00004. Pharmacoeconomics. 2002. PMID: 11817991 Clinical Trial.
-
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.N Engl J Med. 1996 Apr 11;334(15):939-45. doi: 10.1056/NEJM199604113341502. N Engl J Med. 1996. PMID: 8596594 Clinical Trial.
Cited by
-
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.Am J Kidney Dis. 2012 Aug;60(2):250-61. doi: 10.1053/j.ajkd.2012.04.012. Epub 2012 Jun 2. Am J Kidney Dis. 2012. PMID: 22658574 Free PMC article.
-
Association between depressive symptoms and mortality risk in chronic kidney disease.Health Psychol. 2010 Nov;29(6):594-600. doi: 10.1037/a0021235. Health Psychol. 2010. PMID: 20939641 Free PMC article.
-
Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population.Diabetes Metab Syndr Obes. 2021 Apr 16;14:1601-1608. doi: 10.2147/DMSO.S300940. eCollection 2021. Diabetes Metab Syndr Obes. 2021. Retraction in: Diabetes Metab Syndr Obes. 2021 Oct 06;14:4179-4180. doi: 10.2147/DMSO.S342648. PMID: 33889001 Free PMC article. Retracted.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical